Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-14005104Phase 4Recruiting
Phase 4, open-label trial of bromfenac sodium in cataract (3 arms), sponsored by The Fourth Hospital of China Medical University. Primary endpoint: Aqueous prostaglandin E2 level. Started Aug 2014; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-14005104.